The identification of Lynch syndrome in Congolese colorectal cancer patients

Autor: Isabelle Soubeyran, Henriette Poaty, J. F. Peko, Charles Gombé Mbalawa, Chandra Aba Gandzion, Deby Gassaye, Jean Bernard Nkoua Bon
Rok vydání: 2017
Předmět:
Adult
Male
0301 basic medicine
congenital
hereditary
and neonatal diseases and abnormalities

Cancer Research
medicine.medical_specialty
Pathology
Time Factors
Colorectal cancer
Pedigree chart
DNA Mismatch Repair
03 medical and health sciences
0302 clinical medicine
Risk Factors
Internal medicine
Confidence Intervals
Prevalence
medicine
Humans
Radiology
Nuclear Medicine and imaging

Family history
neoplasms
Immunodeficiency
Mismatch Repair Endonuclease PMS2
business.industry
nutritional and metabolic diseases
Hematology
General Medicine
Middle Aged
Epithelial Cell Adhesion Molecule
medicine.disease
Colorectal Neoplasms
Hereditary Nonpolyposis

digestive system diseases
Confidence interval
Lynch syndrome
Pedigree
DNA-Binding Proteins
Cross-Sectional Studies
MutS Homolog 2 Protein
030104 developmental biology
Congo
Oncology
MSH2
030220 oncology & carcinogenesis
Female
Colorectal Neoplasms
MutL Protein Homolog 1
business
Cohort study
Zdroj: Bulletin du Cancer. 104:831-839
ISSN: 0007-4551
DOI: 10.1016/j.bulcan.2017.08.005
Popis: Summary Background We aimed to investigate the prevalence of Lynch syndrome as one of hereditary causes of colorectal cancer (CRC) among young Congolese individuals affected by the CRC, and to define methods for diagnosis in Congo Brazzaville. Methods We conducted a transversal cohort study of 34 patients having a CRC with a family history for a period of eight years. They were selected among 89 CRCs of any type from the Bethesda guidelines criteria combined with pedigrees. Mismatch repair (MMR) genes alterations were researched by immunohistochemistry (IHC). Results We identified with the Bethesda criteria a total of 38.2% (34/89) patients having familial CRC with a confidence interval (CI) of 95% = [0.34–0.41]. Only 14.7% (5/34) 95% CI = [0.34–2.32] patients showed MMR immunodeficiency involving firstly MLH1 protein then MSH2 protein. These data account for 5.6% (5/89) 95% CI = [0.15–0.33] of patients affected by Lynch syndrome with an earlier median age of 35 years (range 20 to 47 years). Conclusion The prevalence of Lynch syndrome found in Brazzaville is comparable to that is found in northern countries. The combined Bethesda guidelines, pedigree and IHC is an accessible and good alternative method for the positive diagnosis of Lynch syndrome in current practice in Congo.
Databáze: OpenAIRE